LIS
DTIL icon

Legacy Investment Solutions’s Precision BioSciences DTIL Stock Holding History

Legacy Investment Solutions’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$15 Hold
3
– – ﹤0.01% 749
2024
Q3 		$25 Buy
+3
New +$29 ﹤0.01% 699

Other funds holding DTIL

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Legacy Investment Solutions's DTIL Position: Q4 2024 in Review

Legacy Investment Solutions held its Precision BioSciences (DTIL) position steady in Q4 2024 at 3 shares worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #749.

Legacy Investment Solutions first reported a position in DTIL in Q3 2024 and has held it in 2 quarters since. The position peaked at $25 in Q3 2024. 55 funds tracked by Wall St. Rank hold DTIL as of Q4 2024.

  • Legacy Investment Solutions held 3 shares of Precision BioSciences worth $15 as of Q4 2024.
  • Legacy Investment Solutions left its Precision BioSciences share count unchanged in Q4 2024.
  • Precision BioSciences made up ﹤0.01% of Legacy Investment Solutions's portfolio in Q4 2024, its #749 holding.
  • Legacy Investment Solutions first reported a position in Precision BioSciences in Q3 2024 and has held it in 2 quarters since.
  • Legacy Investment Solutions's Precision BioSciences position peaked at $25 in Q3 2024.
  • 55 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2024.

Based on Legacy Investment Solutions's 13F filing for Q4 2024, filed 14 Feb 2025.